Patient Selection Shapes Herbal Medicine Trial Results
Trials that selected patients by traditional Chinese medicine patterns reported significant primary outcomes more often, a link that needs rigorous testing.
Updated on Nov. 5, 2026 in Alternative Medicine

A new analysis of 378 published randomized placebo-controlled trials of Chinese herbal formulas found that trials using traditional Chinese medicine patterns as a patient-selection criterion reported statistically significant primary outcomes more often than trials that did not. The findings matter most to readers considering traditional Chinese herbal products and to researchers designing future trials.
Why it matters
Traditional Chinese medicine often selects patients by 'patterns,' a diagnostic framework based on individual symptom profiles rather than a single disease label, and this analysis suggests that how patients are chosen may shape whether trials appear to work. Because the association was observed across published trials rather than in a controlled comparison, it raises questions about study design and selection effects that the field still needs to resolve.
The analysis pooled 378 published randomized placebo-controlled trials of Chinese herbal formulas, covering 92,691 participants in primary outcome analyses. Pattern-based trials reported significant primary outcomes more often than non-pattern trials, but only 13.8% of the trials were rated low risk of bias, so the association should be treated as preliminary.
The players
News-Medical.net
A medical news and research information website that publishes summaries of peer-reviewed health and clinical studies.
The details
Traditional Chinese medicine practitioners often assign a 'pattern' to each patient, a diagnostic category built from a combination of symptoms, pulse, and tongue signs, and then select herbal formulas to match that pattern. When trials require patients to meet a pattern before enrolling, the participants may be more uniform in their presentation and more likely to respond to the chosen formula. The analysis classified trials by whether they used this criterion and then adjusted for four prespecified trial characteristics to isolate the association.
Timeline
Trials analyzed were published between January 1, 2020, and October 21, 2025.
The analysis was published on November 5, 2026, in news-medical.net.
Health Landscape
Randomized placebo-controlled trials remain the reference standard for judging whether an intervention works, and herbal medicine research has increasingly been held to that standard. This analysis adds evidence that trial design choices, particularly how patients are selected, can shape reported results in the traditional Chinese medicine literature.
If you use traditional Chinese herbal products, the finding is a reminder that trial results depend heavily on how participants were chosen and how well the studies were designed. Worth discussing with your doctor before starting or changing any herbal product, especially if you take other medications.
The takeaway
Patient-selection rules can change what a trial appears to show, so the strength of any herbal claim depends on study rigor as well as on reported results. Ask your physician or a qualified clinician to help you weigh the evidence before making decisions about herbal treatments.
Further reading
For broader context on how these therapies are studied and regulated, explore our Alternative Medicine coverage.
Source note: This article includes information reported by News-Medical.


